Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114


CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Bennett JL, Elhofy A, Charo I, Miller SD, Dal Canto MC, Karpus WJ.

Viral Immunol. 2007 Spring;20(1):19-33.


IFN╬│ influences type I interferon response and susceptibility to Theiler's virus-induced demyelinating disease.

Bowen JL, Olson JK.

Viral Immunol. 2013 Aug;26(4):223-38. doi: 10.1089/vim.2013.0004. Epub 2013 Jul 5.


Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.

Christophi GP, Massa PT.

Viral Immunol. 2009 Dec;22(6):371-87. doi: 10.1089/vim.2009.0052.


CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology.

Begolka WS, Haynes LM, Olson JK, Padilla J, Neville KL, Dal Canto M, Palma J, Kim BS, Miller SD.

J Neurovirol. 2001 Oct;7(5):409-20.


TLR3 signaling is either protective or pathogenic for the development of Theiler's virus-induced demyelinating disease depending on the time of viral infection.

Jin YH, Kaneyama T, Kang MH, Kang HS, Koh CS, Kim BS.

J Neuroinflammation. 2011 Dec 21;8:178. doi: 10.1186/1742-2094-8-178.


Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.

Bowen JL, Olson JK.

J Immunol. 2009 Dec 1;183(11):6971-80. doi: 10.4049/jimmunol.0902193. Epub 2009 Nov 4.


Anticapsid immunity level, not viral persistence level, correlates with the progression of Theiler's virus-induced demyelinating disease in viral P1-transgenic mice.

Myoung J, Bahk YY, Kang HS, Dal Canto MC, Kim BS.

J Virol. 2008 Jun;82(11):5606-17. doi: 10.1128/JVI.02442-07. Epub 2008 Mar 19.


IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.

Kim BS, Jin YH, Meng L, Hou W, Kang HS, Park HS, Koh CS.

J Neuroinflammation. 2012 Sep 17;9:217. doi: 10.1186/1742-2094-9-217.


Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.

Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, Miller SD.

J Clin Invest. 1999 Sep;104(5):599-610.


The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Kaneyama T, Tomiki H, Tsugane S, Inaba Y, Ichikawa M, Akiba H, Yagita H, Kim BS, Koh CS.

Int Immunol. 2014 Jul;26(7):369-81. doi: 10.1093/intimm/dxt056. Epub 2014 Jan 31.


Cytokine/chemokine profile in J774 macrophage cells persistently infected with DA strain of Theiler's murine encephalomyelitis virus (TMEV).

Himeda T, Okuwa T, Muraki Y, Ohara Y.

J Neurovirol. 2010 May;16(3):219-29. doi: 10.3109/13550284.2010.484040.


Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination.

Miller SD, Gerety SJ, Kennedy MK, Peterson JD, Trotter JL, Tuohy VK, Waltenbaugh C, Dal Canto MC, Lipton HL.

J Neuroimmunol. 1990 Jan;26(1):9-23.


A critical role for virus-specific CD8(+) CTLs in protection from Theiler's virus-induced demyelination in disease-susceptible SJL mice.

Getts MT, Richards MH, Miller SD.

Virology. 2010 Jun 20;402(1):102-11. doi: 10.1016/j.virol.2010.02.031. Epub 2010 Apr 8.


Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.

Richards MH, Getts MT, Podojil JR, Jin YH, Kim BS, Miller SD.

J Autoimmun. 2011 Mar;36(2):142-54. doi: 10.1016/j.jaut.2010.12.005. Epub 2011 Jan 26.


Oral administration of live virus protects susceptible mice from developing Theiler's virus-induced demyelinating disease.

Kang BS, Yahikozawa H, Koh CS, Kim BS.

Virology. 2007 Sep 15;366(1):185-96. Epub 2007 May 16.

Items per page

Supplemental Content

Write to the Help Desk